Growth through expansion Ionisos operates a growing European footprint with 10 sites across France, Germany, Spain, Estonia, and Switzerland, signaling ongoing capacity expansion and potential cross-border sterilization capabilities to meet regional demand.

Strategic acquisitions Past acquisitions such as Stermed and ongoing facility development in Germany indicate a growth-by-acquisition strategy that may create opportunities to upsell integrated sterilization services and broaden service offerings to new customers.

Radiation sterilization focus Specialization in gamma irradiation for sterilization, preservation, decontamination, and crosslinking positions Ionisos as a potential partner for medical devices, cosmetics, and pharmaceutical packaging manufacturers seeking reliable sterilization and contract manufacturing support.

Small to mid-market opportunity With revenue under $1M and a mid-sized employee base, Ionisos represents a target for growth-oriented suppliers, equipment upgrades, and service partnerships that can scale with their expanding European operations.

Tech-enabled operations Adoption of cloud and enterprise tools (AWS, Azure, WordPress, iCIMS, Microsoft 365) suggests openness to digital transformation and vendor solutions for process optimization, data reporting, and customer experience enhancements.